Author:
Argall Aaron D.,Koenig Sara N.,Mohler Peter J.
Publisher
Springer International Publishing
Reference89 articles.
1. Stevens TL, Wallace MJ, El Refaey M, Roberts JD, Koenig SN, Mohler PJ. Arrhythmogenic cardiomyopathy: molecular insights for improved therapeutic design. J Cardiovasc Dev Dis. 2020;7(2):21.
2. Xiao B, Zhong G, Obayashi M, Yang D, Chen K, Walsh MP, et al. Ser-2030, but not Ser-2808, is the major phosphorylation site in cardiac ryanodine receptors responding to protein kinase A activation upon β-adrenergic stimulation in normal and failing hearts. Biochem J. 2006;396(1):7–16.
3. Wehrens XHT, Lehnart SE, Reiken S, Vest JA, Wronska A, Marks AR. Ryanodine receptor/calcium release channel PKA phosphorylation: a critical mediator of heart failure progression. Proc Natl Acad Sci U S A. 2006;103(3):511–8.
4. Grandi E, Bers DM. Models of the ventricular action potential in health and disease. In: Zipes DP, Jalife J, Stevenson WG, editors. Cardiac electrophysiology: from cell to bedside. 6th ed. Philadelphia, PA: Elsevier; 2014. p. 319–30.
5. Solaro RJ, Moir AJG, Perry SV. Phosphorylation of troponin I and the inotropic effect of adrenaline in the perfused rabbit heart. Nature. 1976;262(5569):615–7.